HIGHLIGHTS
- who: Knut Hestad from the University of Lucerne, Switzerland have published the article: Neurocognitive Outcome and Compensating Possibilities in Children and Adolescents Treated for Acute Lymphoblastic Leukemia With Chemotherapy Only, in the Journal: (JOURNAL)
- what: In sum, during the last decade there has been a growing research focus on neurocognitive sequelae/consequences after treatment for ALL in childhood. The aim of this study is thus to examine neuropsychological differences between survivors of childhood ALL with no relapse, treated with CTO, compared to matched healthy controls, using an extensive neuropsychological test battery generating the possibility of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.